Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M12,897Revenue $M13,606Net Margin (%)10.1Altman Z-Score1.4
Enterprise Value $M12,312EPS $1.1Operating Margin %15.7Piotroski F-Score5
P/E(ttm)32.1Beneish M-Score-2.7Pre-tax Margin (%)13.5Higher ROA y-yN
Price/Book0.910-y EBITDA Growth Rate %10.1Quick Ratio2.8Cash flow > EarningsY
Price/Sales3.35-y EBITDA Growth Rate %11.6Current Ratio3.2Lower Leverage y-yN
Price/Free Cash Flow16.8y-y EBITDA Growth Rate %36.9ROA % (ttm)4.5Higher Current Ratio y-yY
Dividend Yield %1.1PEG2.8ROE % (ttm)9.8Less Shares Outstanding y-yY
Payout Ratio %33.0Shares Outstanding M388ROIC % (ttm)11.5Gross Margin Increase y-yN

Gurus Latest Trades with MKGAY

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

MKGAY is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

MKGAY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about MKGAY:

    News about MKGAY:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Merck and Pfizer Receive Positive Opinion for Orphan Drug Designation for Avelumab in Merkel Cell... Nov 25 2015
    Merck KGaA Earnings Q3, 2015 Nov 24 2015
    Sigma-Aldrich Corporation -- Moody's downgrades Sigma Aldrich's long term issuer rating to Baa1,... Nov 20 2015
    Merck Counts on Africa for Growth Nov 20 2015
    Merck and the University of Cape Town to Develop a Drug Discovery Platform for Malaria Nov 19 2015
    Merck Completes Sigma-Aldrich Acquisition Nov 18 2015
    Merck Reports Jump in Earnings in Q3 2015 Nov 12 2015
    Merck Set to Complete Sigma-Aldrich Acquisition Nov 10 2015
    Merck Recognized for Digital Workplace Platform Nov 06 2015
    Karl-Ludwig Kley Joins Verizon Board of Directors Nov 05 2015
    Merck Introduces Spectroquant® Prove Nov 05 2015
    Merck Hosts Hall of Fame of German Research for the First Time Nov 04 2015
    Merck and Pfizer Announce Initiation of Phase III First-Line Trial of Avelumab in Patients with... Nov 04 2015
    Merck’s Glucophage® Extended Release (XR) Can be Used for More Type 2 Diabetes Patients Nov 03 2015
    Merck Named as Top Employer by Science Magazine Nov 02 2015
    Merck Appoints Laszlo Radvanyi as Head of Global Immuno-Oncology Research Nov 02 2015
    Experts to Explore new Smart Materials at “Displaying Futures” Symposium Nov 02 2015
    Merck and Selvita Announce Drug Discovery Collaboration Nov 02 2015
    Merck KGaA – Value Analysis (US OTC:MKGAY) : October 28, 2015 Oct 28 2015
    Merck Millipore Introduces Parteck® SRP 80 Excipient for Sustained-Release Oral Solid Dose... Oct 26 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)